SC
SWAV

Scholtz & Company’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Scholtz & Company’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,672
Closed -$7.06M – 56
2024
Q1 		$7.06M Buy
21,672
+2,322
+12% +$570K 3.12% 13
2023
Q4 		$3.69M Buy
19,350
+18,288
+1,722% +$3.46M 1.83% 20
2023
Q3 		$211K Sell
1,062
-11,242
-91% -$2.66M 0.14% 38
2023
Q2 		$3.51M Buy
+12,304
New +$3.42M 2.2% 18

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Scholtz & Company's SWAV Position: Q2 2024 in Review

Scholtz & Company sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 21,672 shares — an estimated $7.06M sold.

Scholtz & Company first reported a position in SWAV in Q2 2023 and held it in 4 quarters. The position peaked at $7.06M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Scholtz & Company reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Scholtz & Company sold 21,672 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $7.06M.
  • Scholtz & Company first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Scholtz & Company's Shockwave Medical, Inc. Common Stock position peaked at $7.06M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Scholtz & Company's 13F filing for Q2 2024, filed 8 Aug 2024.